CTN-0095-A-2: Reducing Stigma Toward People with Opioid Use Disorder Among Primary Care Clinicians
Stephanie Hooker, PhD, MPH, MS
Co-Lead Investigator
HealthPartners Institute for Education & Research
Stephanie.A.Hooker@HealthPartners.com
Rebecca Rossom, MD, MSCR
Co-Lead Investigator
HealthPartners Institute for Education & Research
rebecca.c.rossom@healthpartners.com
Gavin Bart, MD, PhD, FACP, FASAM
Co-Lead Investigator
Addiction Medicine
Minneapolis Medical Research Foundation
bartx005@umn.edu
In one of the study health systems primary care clinicians (PCCs) in clinics randomized to the intervention in COMPUTE 2.0 will be randomized 1:1 to the stigma reduction or comparison training, stratified by clinic and waiver status. Training will be conducted via online learning software. PCCs will be asked to complete a brief training on the clinical decision support tool. PCCs in the stigma reduction intervention will hear patient narratives designed to reduce stigma about patients with opioid use disorder (OUD). PCCs in the comparison training will not get any stigma content but will have training on using the clinical decision support tool. Immediately following the training, the PCCs will complete a survey of stigma beliefs and intentions to get waivered to prescribe buprenorphine and to prescribe buprenorphine. Use of the CDS will be monitored in both groups for 6 months. Secondary outcomes will include measures of PCC behavior, including prescribing behavior and new waivers among previously non-waivered PCCs.
Funded by the NIH HEAL InitiativeSM.
Related Studies
- CTN-0095: Clinic-Randomized Trial of Clinical Decision Support for Opioid Use Disorders in Medical Settings
- CTN-0095-A-1: Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder
Related Resources
Node Involvement
Lead Node(s):
All Participating Nodes: